1 (EC 1.4.3.4) are homodimeric flavoenzymes found in the outer membrane of mitochondria of higher eukaryotes and are expressed in a tissue-specific manner (2). These enzymes catalyze the oxidation of primary, secondary, and tertiary amines to imines with concomitant reduction of oxygen to hydrogen peroxide (3). The physiological role of MAO B is to oxidize exogenous and endogenous amines, many of which could mimic the function of neurotransmitters. MAO A oxidizes neurotransmitters such as serotonin, dopamine, and norepinephrine. The structures and mechanisms of these enzymes are currently being investigated. The gene sequences of both MAO A and B from human liver have been determined to be ϳ70% identical (4). A covalently bound FAD cofactor is present in either enzyme, attached to a conserved cysteinyl residue (Cys-406 in MAO A and Cys-397 in MAO B) via an 8␣-S-cysteinyl flavin linkage (Scheme 1). Neither the need for covalent FAD attachment nor the mechanism of covalent incorporation is known. Covalent attachment of flavin cofactors has been found in more than 20 proteins that catalyze a variety of reactions in both prokaryotes and eukaryotes (5). The processes by which flavins are incorporated into proteins appear to differ and to vary in complexity. The simplest known system is the heterodimeric p-cresol-methylhydroxylase from Pseudomonas putida. The enzyme is capable of autoflavinylation in vitro (formation of an 8␣-O-tyrosyl-FAD), requiring only the recombinantly produced purified flavin-binding subunit, a separately expressed and purified heme-containing subunit, and FAD (6). Flavinylation of the mitochondrial matrix enzyme succinate dehydrogenase to form 8␣-N(3)-histidyl-FAD appears to be more complex than that of p-cresol-methylhydroxylase. In vitro studies indicate that flavinylation requires the presence of other factors including molecular chaperones, ATP, and effector molecules such as succinate, fumarate, or malate (7). These additional factors have been suggested to aid in folding the enzyme into a conformation that permits covalent attachment of the flavin (8). Flavinylation of MAO B has been examined by its expression in riboflavin-depleted COS-7 cells (9, 10). Electroporation of these cells with a cDNA encoding MAO B and either FAD or 8␣-hydroxy-FAD results in the production of catalytically active enzyme. In the absence of added FAD, the inactive apoenzyme form of MAO B is produced. These results have been suggested to support a flavinylation mechanism for MAO B involving additional factors that would process and activate the 8␣ position of the flavin prior to covalent attachment (9, 11).
Monoamine oxidases A and B (MAO A and MAO B)
1 (EC 1.4.3.4) are homodimeric flavoenzymes found in the outer membrane of mitochondria of higher eukaryotes and are expressed in a tissue-specific manner (2) . These enzymes catalyze the oxidation of primary, secondary, and tertiary amines to imines with concomitant reduction of oxygen to hydrogen peroxide (3) . The physiological role of MAO B is to oxidize exogenous and endogenous amines, many of which could mimic the function of neurotransmitters. MAO A oxidizes neurotransmitters such as serotonin, dopamine, and norepinephrine. The structures and mechanisms of these enzymes are currently being investigated. The gene sequences of both MAO A and B from human liver have been determined to be ϳ70% identical (4) . A covalently bound FAD cofactor is present in either enzyme, attached to a conserved cysteinyl residue (Cys-406 in MAO A and Cys-397 in MAO B) via an 8␣-S-cysteinyl flavin linkage (Scheme 1). Neither the need for covalent FAD attachment nor the mechanism of covalent incorporation is known. Covalent attachment of flavin cofactors has been found in more than 20 proteins that catalyze a variety of reactions in both prokaryotes and eukaryotes (5) . The processes by which flavins are incorporated into proteins appear to differ and to vary in complexity. The simplest known system is the heterodimeric p-cresol-methylhydroxylase from Pseudomonas putida. The enzyme is capable of autoflavinylation in vitro (formation of an 8␣-O-tyrosyl-FAD), requiring only the recombinantly produced purified flavin-binding subunit, a separately expressed and purified heme-containing subunit, and FAD (6) . Flavinylation of the mitochondrial matrix enzyme succinate dehydrogenase to form 8␣-N(3)-histidyl-FAD appears to be more complex than that of p-cresol-methylhydroxylase. In vitro studies indicate that flavinylation requires the presence of other factors including molecular chaperones, ATP, and effector molecules such as succinate, fumarate, or malate (7) . These additional factors have been suggested to aid in folding the enzyme into a conformation that permits covalent attachment of the flavin (8) . Flavinylation of MAO B has been examined by its expression in riboflavin-depleted COS-7 cells (9, 10) . Electroporation of these cells with a cDNA encoding MAO B and either FAD or 8␣-hydroxy-FAD results in the production of catalytically active enzyme. In the absence of added FAD, the inactive apoenzyme form of MAO B is produced. These results have been suggested to support a flavinylation mechanism for MAO B involving additional factors that would process and activate the 8␣ position of the flavin prior to covalent attachment (9, 11) .
Flavin analogues that have modifications in the isoalloxazine ring or in the ribityl side chain have been used extensively to address structure-activity and mechanistic questions in flavoproteins containing non-covalently bound flavin coenzymes (12) . The application of this approach to those flavoenzymes containing covalently bound flavins has not been extensively investigated due to the technical limitations involved in introducing flavin analogues into a covalent linkage with the protein. The pioneering work of Lambooy and co-workers (13) (14) (15) first demonstrated the possibility of using flavin analogues as probes of structure and mechanism in this subclass of flavoenzymes. These studies involved feeding flavin analogues with modifications in the 7 and 8 positions of the flavin ring to riboflavin-deficient rats. The activities of MAO and succinate dehydrogenase (SDH) were determined and compared with riboflavin-fed control animals. Incorporation of 8␣-methylriboflavin and 7␣-methylriboflavin into succinate dehydrogenase and into MAO was shown using 14 C-labeled analogues. Some catalytic activity was observed for both enzymes when either flavin analogue or no flavin analogue was present in the diet, although the level of activity depended on which riboflavin analogue was used and which tissue sample was analyzed. This work was limited in that it was not possible to isolate sufficient quantities of enzyme for detailed kinetic and structural analysis. Additionally, the number of analogues that could be tested was limited due to the anti-vitaminic activity of some flavins in whole animals. Later studies (16) investigating the covalent incorporation of flavin analogues into succinate dehydrogenase used yeast strains deficient in the biosynthesis of riboflavin. This allowed the use of several flavin analogues as probes for their ability to be incorporated and function catalytically in yeast SDH (17) . Preparations of yeast succinate dehydrogenase were catalytically active with either 7␣-methylriboflavin or 8␣-methylriboflavin. The 8␣-methylriboflavin analogue was demonstrated to be covalently incorporated into SDH by isolation and analysis of the respective flavin-containing peptide (17) .
The recent successful expression of the human liver MAO A and MAO B genes in Saccharomyces cerevisiae (18, 19) prompted us to develop a riboflavin-deficient yeast strain as a system to study the incorporation of flavin analogues as substitutes for the normal flavin in MAO A and B. Such a system would allow experimental approaches to probe the effects of structural alterations of the flavin coenzyme on the catalytic properties of either MAO A or MAO B as well as the structural requirements of the flavin molecule necessary for covalent flavin incorporation into these enzymes. By separately expressing MAO A or MAO B, such a system avoids the difficulties of interpretation of results from the animal system, where both MAO A and MAO B are expressed in most tissues. For those flavin analogues that are covalently incorporated into MAO, new insights into the mechanistic role of the flavin coenzyme in catalysis might be determined. With the yeast expression system it should be possible to isolate sufficient quantities of MAO to allow structural and kinetic analysis of the enzyme forms produced with various flavin analogues and possibly provide new insights into the mechanistic role of the flavin in catalysis.
This work describes two systems for the covalent incorporation of flavin analogues with alterations in the isoalloxazine ring or in the ribityl side chain into MAO A or MAO B. Flavinylation is monitored by the expression of catalytically functional enzymes and from the use of flavin-specific antisera as described by Barber et al. (20) . Those flavin analogues whose structures prevented covalent incorporation or were not converted to their FAD coenzyme form failed to support any catalytic activity with either enzyme. Conversely, all flavin analogues that were covalently bound to either enzyme did support catalytic activity. Structural analysis of MAO A expressed in the presence of 7-nor-7-bromoriboflavin demonstrated that covalent incorporation occurred at Cys-406 at the 8␣ position of the flavin. Flavin analogues with 8-nor-8-halogen substituents were incorporated into either enzyme as the 8-nor-8-S-thioflavin. Both MAO A and MAO B exhibit similar specificities for flavin analogue incorporation.
EXPERIMENTAL PROCEDURES
Yeast Strains-Genotypes of all yeast strains are shown in Table I (18, 19) . RM3 yeast cultures were grown and induced in media supplemented with 50 mg/liter riboflavin or flavin analogue. All cultures containing free riboflavin were protected from light at all times to prevent flavin photodegradation and any degradative effects on the cells.
Plasmids and RIB5 Gene Disruption-The URA3/ADE2 plasmids pYeDP60HMAOA and pYeDP60HMAOB, used to express MAO A and MAO B in S. cerevisiae strains W303.1B and RM2, were the generous gift of Dr. Philippe Urban and have been described previously (18) . Higher levels of MAO A expression were achieved using pGPD(G)-2MA3Јut (kindly provided by Dr. James Salach) in strains RH218 (19) and RM3.
Disruption of the URA3 locus to produce strain RM1 was accomplished by transformation of strain RH218 with the 4.6-kb HindIII fragment of pSR299 (gift of Dr. Sue Jinks-Robertson, Emory University) which contains a deletion mutant of the URA3 coding sequence. Transformants were selected for their ability to survive in the presence of 5-fluoroorotic acid. Strains RM1 and W303.1B were made auxotrophic for riboflavin through replacement of portions of the promoter and the N-terminal coding region of the RIB5 gene with a functional copy of the URA3 gene. This gene disruption cassette was created through polymerase chain reaction amplification of the RIB5 gene and 1 kb of flanking sequences on either side of the gene. The PCR template was total genomic DNA from strain W303.1B using oligonucleotides RIB5FWD (5Ј-AACTGTTTGTCTGCACTCTCTAACT) and RIB5REV (5Ј-TTCAGCGTCCTGAGAAGCATTCGG). The 2.6-kb PCR product was subcloned using the TA cloning kit (Invitrogen) to give vector pCRIIRib5. Partial digestion of pCRII-Rib5 with EcoRI resulted in a 2.6-kb band that was subsequently cloned into the EcoRI site of pGem7 (Promega) to give pGem7-Rib5. Digestion of pGem7-Rib5 with KpnI and EcoRV removed the promoter elements and 364 base pairs of the Nterminal coding sequence of Rib5 that was replaced with the 5.14-kb KpnI-EcoRV partial digestion product of pHUKH1 (22) (gift of Dr. Gray Crouse, Emory University) to give p⌬Rib5-Kan R . The kanamycin resistance cassette of p⌬Rib5-Kan R was excised by PstI digestion and the plasmid religated to give p⌬Rib5. Strains W303.1B and RM2 were transformed with the 6.1-kb XbaI-SacI fragment of p⌬Rib5 and transformants selected for uracil prototrophy on plates containing riboflavin (50 mg/liter). Riboflavin auxotrophs selected by this procedure were confirmed by PCR of genomic DNA in addition to their inability to grow in the absence of riboflavin. Uracil auxotrophy was recovered in strain RM2 through excision of the URA3 gene via hisG repetitive sequences flanking the URA3 gene (23) . Selection for gene excision was accomplished after growth in rich media for several generations followed by plating on 5-fluoroorotic acid containing synthetic media supplemented with riboflavin (50 mg/liter).
Demonstration of the Ability of rib5 Yeast to Convert Exogenous Riboflavin to FMN and FAD-Riboflavin, tritiated at the 5Ј-hydroxymethyl (12.6 mCi/mmol), was synthesized as described (24) . RM2 yeast were grown to late logarithmic phase in the presence of 20 mg/liter of the tritiated cofactor. Total non-covalently bound flavin coenzymes were isolated (25) and chromatographed on reverse-phase HPLC (24) using authentic unlabeled standards (riboflavin, FMN, and FAD) as controls. Fractions were collected, and radioactivity in each fraction was determined by scintillation counting. Determination of Free Cytosolic FAD-Cytosol (60 -70 mg of protein in 8 ml) was isolated from lysates of W303.1B or RM2 yeast as described (18) . Small molecules were separated from protein material on a BioGel P2-DG (Bio-Rad) gel filtration column (2.5 ϫ 20 cm) equilibrated with 25 mM Tris base, pH 7.4, 1 mM EDTA, 0.6 M sorbitol. Fractions (5.4 ml) were collected and analyzed for fluorescence ( ex 267 nm, em 525 nm). Those exhibiting fluorescence were purified and concentrated using a C18 Sep-Pak cartridge (Waters Associates).
Apoglucose oxidase was prepared from 80 mg (total weight) of the Aspergillus niger holoenzyme (Sigma type V) as described (26) with the following changes. Apoenzyme eluting from the desalting column was collected in 3-ml fractions into 9 ml of 0.5 M potassium phosphate, pH 7.0. Fractions containing significant absorbance at 280 nm were pooled and concentrated to 10 ml followed by overnight dialysis against 4 liters of 50 mM potassium phosphate, pH 6.8. The final solution (1 mg/ml protein) was stored on ice and was stable for several weeks. The apoenzyme exhibited less than 1% of the glucose oxidase activity of the FAD-reconstituted enzyme.
Reconstitution assays utilized a modification of the peroxidase-coupled MAO assay described by Holt et al. (27) and were conducted with either commercial FAD or total flavins purified from yeast cell lysates. Apoglucose oxidase (5 g) was added to a FAD solution or a solution of flavins purified from yeast in 50 mM potassium phosphate, pH 7.0, with 0.1% (w/v) bovine serum albumin. After overnight incubation at room temperature, samples were assayed by hydrogen peroxide formation upon glucose addition. Assays were conducted at 30°C in 50 mM potassium phosphate, pH 7.0, 0.5 M D-glucose, 1% (w/v) bovine serum albumin, 4 mM aminoantipyrine, 8 mM vanillic acid, and 40 g/ml peroxidase (Sigma). The rate of formation of a colored complex between peroxidase-oxidized 4-aminoantipyrine and vanillic acid ( max 498 nm
) (27) was determined and equated to the rate of glucose oxidase catalyzed hydrogen peroxide formation.
Expression, Digitonin Solubilization, and Purification of Recombinant MAO A and MAO B-MAO A and MAO B were expressed in S. cerevisiae strain RM2 containing plasmids pYeDP60HMAOA or pYeDP60HMAOB as described (18) with the addition of 50 mg/liter riboflavin during growth. Cells were washed with distilled water prior to incubation in galactose-containing medium. Mitochondria were isolated as described (18) with the addition of protease inhibitors (2 g/ml aprotinin, 0.5 g/ml leupeptin, 1 g/ml pepstatin A, 0.1 mM benzamidine, and 0.1 mM sodium metabisulfite) prior to spheroplast lysis. Solubilization of MAO from outer mitochondrial membranes was performed by dilution of total mitochondrial protein to 2 mg/ml with solubilization buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 0.6 M sorbitol, 25% glycerol) followed by the addition of an equal volume of 0.8 mg/ml digitonin (Sigma) in solubilization buffer. Samples were incubated on a tube rotator at 4°C for 30 min and centrifuged at 9000 ϫ g for 15 min at 4°C to remove insoluble material. Supernatants were decanted and centrifuged at 252,000 ϫ g for 45 min at 4°C producing a bright yellow pellet that contained highly enriched MAO. This pellet was resuspended by homogenization in solubilization buffer and diluted with the same to a protein concentration of 0.2 mg/ml.
Expression of MAO A in S. cerevisiae strain RM3 was conducted in two 12-liter fermenters (New Brunswick Scientific) as described (19) with the addition of 50 mg/liter riboflavin or flavin analogue during growth and induction.
Protein concentrations in either crude yeast mitochondrial fractions or in purified protein preparations were determined using a slight modification of the method of Bearden (28) . Suspensions of crude mitochondria or digitonin-solubilized protein fractions were diluted with sodium hydroxide (final concentration, 10 mM) prior to colorimetric protein determination. This treatment resulted in more reproducible protein determinations due to more efficient protein solubilization.
Enzyme Assays-The kynuramine oxidase activity of MAO A was determined fluorometrically at 30°C as described (29) with the exception that 2% (w/v) reduced Triton X-100 was added to the assay buffer. Benzylamine oxidase activity of MAO B was determined at 30°C using a peroxidase-linked spectrophotometric assay (27) and was measured at 1 mM O 2. This condition gave more reproducible assay values since this O 2 concentration is approximately four times the K m O 2 of bovine liver MAO B (30) .
Polyclonal Antibody Production-Rabbit polyclonal antisera to recombinant human liver MAO A (anti-MAO antibody) purified from RH218 S. cerevisiae was produced by HTI Bio-Products, Santa Ysabel, CA. This antiserum cross-reacts with recombinant human liver MAO B as well and was used for detection of either MAO A and MAO B. Rabbit antisera specific for covalently bound flavins (anti-flavin antibody) were obtained using the hapten N-6-(6-aminohexyl)-FAD conjugated to bovine serum albumin (a gift from Dr. Mike Barber, University of South Florida College of Medicine, Tampa, FL) as described (20) . Rabbit injections and serum bleeds were done by abV Immune Response, Inc. (Derry, NH).
SDS-PAGE and Immunoblotting-SDS-PAGE separation of proteins from digitonin-solubilized mitochondria was conducted according to Laemmli (31) using 7.5% polyacrylamide gels. Proteins were transferred to nitrocellulose membranes using a Bio-Rad Mini Trans-Blot apparatus in blot buffer (25 mM Tris base, 192 mM glycine, 20% (v/v) methanol) for 1 h at 100 V. For blots using the anti-MAO antisera, the membrane was blocked with 3% gelatin in TTBS (137 mM NaCl, 2.7 mM KCl, 25 mM Tris base, pH 8.0, 0.2% Tween 20) for 30 min at room temperature. Anti-flavin blots were blocked with WBT (20 mM Tris base, pH 7.4, 0.3 M NaCl, 0.05% Tween 20) for 30 min at room temperature and washed in TTBS. Primary antibodies were diluted in antibody buffer (1% (w/v) gelatin in TTBS). Antisera to MAO A was diluted 1:5000 for use in anti-MAO blots, and the anti-flavin antisera was diluted 1:1250. Antibody solutions were added to the blots and allowed to incubate at room temperature for 1 h. Blots were washed twice in TTBS and incubated with either goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Sigma, for the anti-MAO blots) or goat anti-rabbit alkaline phosphatase-conjugated secondary antibody (Sigma, for the anti-flavin blots). Both secondary antibodies were diluted 1:3000 in antibody buffer. The anti-MAO and anti-flavin blots were developed using 3,3Ј-diaminobenzidine tetrahydrochloride and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium, respectively.
The anti-MAO A antiserum could detect a minimum of 2 ng of MAO A and 10 ng of MAO B. The anti-flavin antiserum recognized either covalently bound FAD or FMN on Western blots and exhibited a sensitivity to MAO A that was 5-10-fold lower than the anti-MAO antibody.
Flavin Analogues-(See Scheme 2 for structures of the riboflavin analogues used in this study.) The following analogues were the generous gifts of Dr. John Lambooy (University of Maryland, Baltimore, Additional quantities of 8-nor-8-chlororiboflavin and 7-nor-7-bromoriboflavin were required for large scale growths of yeast auxotrophic for riboflavin. These analogues were synthesized as described by Lambooy (32) using 3-chloro-4-methylaniline (Aldrich) and 3-methyl-4-bromoaniline (Lancaster), respectively, as starting materials. 2Ј-Deoxyriboflavin was synthesized as described (33) .
Synthesis of 7,8-Nor-8-Chlororiboflavin and 7,8-Nor-7-Chlororiboflavin-
The synthesis of these compounds followed the procedure described for 8-nor-8-chlororiboflavin (32) using 5-chloro-2-nitroaniline (Aldrich) and 4-chloro-2-nitroaniline (Aldrich), respectively, as precursors. A mixture of both products resulted which were partially separated by chromatography on a Bio-Gel P-2 (Bio-Rad) column (2.5 ϫ 20 cm) in water. 7,8-Nor-8-chlororiboflavin eluted prior to 7,8-nor-7-chlororiboflavin. Final purification was accomplished by reverse-phase HPLC on an analytical MicrosorbMV C-18 column (Rainin) using a linear gradient from 0 to 60% (v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid with a flow rate of 1 ml/min with 7,8-nor-8-chlororiboflavin eluting prior to 7,8-nor-7-chlororiboflavin. Identities of these two compounds were confirmed by 1 H NMR. UV-visible absorption properties of the synthesized analogues were as follows: 7,8-nor-8-chlororiboflavin max ϭ 216, 263, 348, and 435 nm and 7,8-nor-7-chlororiboflavin max ϭ 222, 269, 336, and 446 nm.
Preparation of 8-Nor-8-S-Thioflavin Peptides, 8-Nor-8-S-(N-Acetylcysteinyl)-Riboflavin and Ser-Gly-Gly-Cys-(8-Nor-8-S-Thioriboflavin)-Tyr-8-Nor-8-S-(N-acetylcysteinyl)-riboflavin was synthesized as described (34)
. Ser-Gly-Gly-Cys-(8-nor-8-S-thioriboflavin)-Tyr was synthesized using the same procedure with an 8:1 molar ratio of the peptide Ser-Gly-Gly-Cys-Tyr (synthesized by the Emory University Microchemical Facility) to 8-nor-8-chlororiboflavin. The mixture was incubated overnight in buffer containing 0.1 M CHES, pH 9.0, at 30°C. The 8-nor-8-S-thioflavin product was isolated by HPLC using the same system as described for 7,8-nor-8-chlororiboflavin and 7,8-nor-7-chlororiboflavin.
Preparation and Purification of Flavin-containing Peptides from MAO A-All procedures were carried out in dark room conditions. Recombinant human liver MAO A (1 nmol) purified as described (19, 35) from RM3 yeast was precipitated by addition of cold trichloroacetic acid to 5% (w/v), centrifuged at 12,000 ϫ g for 10 min, and washed twice with 5% (w/v) trichloroacetic acid. The pellet was gently washed in 0.5 ml of 0.1 M Tris base, pH 8.0, and then homogenized into the same. Trypsin and chymotrypsin (Sigma) were added in a 1:4 (w/w) ratio of protease to MAO A. Proteolysis was conducted at 37°C for 16 h. Crotalus adamanteus venom phosphodiesterase I (7.5 milliunits, Sigma) was added and incubation continued for at least 2 h to convert FAD peptides to their FMN form. Trichloroacetic acid was added to 5% (w/v), and the sample was centrifuged for 10 min at 12,000 ϫ g. The supernatant was removed and subjected to HPLC separation on a Rainin Phase-Sep Spherisorb C18 column. Elution of peptides was accomplished with a 60-min linear gradient from 3 to 40% (v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid. A Gilson model 112 fluorescence detector ( ex filter 334 -346 nm, em filter 406 -650 nm) was used to detect fluorescent peptides. Samples exhibiting fluorescence were lyophilized and resuspended in 0.1 M potassium phosphate, pH 5.5. The flavin 5Ј-phosphate was removed by incubation with potato acid phosphatase (0.13 units, Sigma) for 24 h at 37°C. Trichloroacetic acid (5% w/v) was added to the samples as before and the pellet resuspended in 3% (v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid. The samples were then rechromatographed on HPLC as described previously. Flavin peptide fractions were pooled, lyophilized, and resuspended in 0.1% (v/v) trifluoroacetic acid and rechromatographed using an Applied Biosystems 140A microbore HPLC equipped with 1000S diode array UV detector.
Peptides were resolved on a ZorbaxSB C18 column (1 mm ϫ 15 cm) using a linear 90-min gradient of 0 -65% (v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid.
MALDI-TOF Mass Spectroscopy and Peptide Sequencing-MALDI-TOF mass spectra were obtained by co-crystallization of a 4:1 (v/v) solution of matrix (saturated solution of ␣-cyano-4-hydroxycinnamic acid in 70% (v/v) acetonitrile with 0.1% (v/v) trifluoroacetic acid) and peptide sample. Data were collected on a Bruker Protein-TOF instrument using the negative ion reflector mode. Peptide sequence data were obtained by the Emory University Microchemical Facility using an Applied Biosystems 477A automated peptide sequencer.
RESULTS

Characterization of rib5 Mutant S. cerevisiae Strains-To
conduct in vivo flavin replacement experiments on MAO A and MAO B, a method to covalently link flavin cofactors other than riboflavin into the enzyme needed to be developed. The work of Oestreicher and co-workers (17) demonstrated that riboflavindeficient S. cerevisiae covalently incorporated flavin analogues into succinate dehydrogenase. Our goal was to create a similar system to probe recombinant human liver MAO A and MAO B. Yeast strains that are auxotrophic for riboflavin have at least one mutation in the six-step riboflavin biosynthetic pathway. The phenotype of these mutations is an absolute requirement SCHEME 2. Structures of riboflavin analogues used in this study. R denotes the D-ribityl side chain.
for exogenously supplied riboflavin for growth (36) .
An initial attempt was made to utilize the same riboflavin auxotrophic yeast strain (ATCC 22550) described in the succinate dehydrogenase flavin replacement studies (17) . However, when a URA3-deficient mutant of this yeast strain was transformed with plasmids encoding either the MAO A or the MAO B gene, little or no expression was observed. The yeast strains described by Urban et al. (18) (W303.1B) and Weyler et al. (19) (RH218) have both been shown to express MAO A, whereas only W303.1B has been reported to express MAO B. We therefore decided to conduct a targeted disruption of the riboflavin synthase (RIB5) gene in both strains. The product of the RIB5 gene catalyzes the terminal step in the riboflavin biosynthetic pathway and was chosen for disruption since it is isolated from other metabolic pathways and would exhibit the phenotype of requiring exogenous riboflavin for growth (37) . After disruption of the RIB5 gene, strain W303.1B was renamed RM2 and strain RH218 was renamed RM3 (genotypes shown in Table I ). Both strains were analyzed for riboflavin auxotrophy. Fig. 1 shows the effect of riboflavin concentrations on the growth of strains RM2 and RM3. Riboflavin levels less than 20 mg/liter in the medium resulted in sub-optimal growth, and no growth is observed when cells were incubated in media containing less than 1 mg/liter riboflavin. Neither additional growth nor an increase in growth rate is observed at higher riboflavin concentrations. Both RIB5-deficient yeast strains RM2 and RM3 display an uncharacterized rho Ϫ phenotype since they are unable to grow on non-fermentable carbon sources such as glycerol (data not shown).
To confirm that imported riboflavin is converted into FMN and FAD in the mutant strains, total cellular flavins were extracted from RM2 yeast grown on 5Ј-[ (38) .
A requirement for covalent incorporation of riboflavin analogues into either MAO A or MAO B is their conversion to the FAD coenzyme level. S. cerevisiae uses a riboflavin kinase (39) and an FAD synthetase (40) to catalyze this conversion as is found in mammalian systems (41) . The following Scheme 3 is operative for flavin analogue incorporation into MAO,
Previous work has shown 5-carba-5-deazariboflavin (42), 7␣-methylriboflavin (17, 43), 8␣-methylriboflavin (17, 43), and 7-nor-7-chloro-8-nor-8-chlororiboflavin (44) are converted to Neither analogue was converted to the FMN form (data not shown) and therefore cannot be transformed into the respective FAD coenzyme analogues. Thus, these two flavin analogues would not be expected to be covalently incorporated into MAO A or B to reconstitute active forms of the respective enzymes.
Expression of MAO A and MAO B in Riboflavin Auxotrophic Yeast Strain RM2-Riboflavin auxotrophic yeast strain RM2 was transformed with the plasmids pYeDP60HMAOA or pYeDP60HMAOB which contain the coding region of the MAO A and MAO B genes, respectively (18) . Expression of the two genes is tightly controlled by a galactose-inducible GAL10/CYC1 promoter. In the absence of galactose, the amount of MAO A synthesized is below the detection limit of either enzyme assay or Western blot analysis of outer mitochondrial membrane extracts probed with a polyclonal anti-MAO antiserum (Fig. 2) .
The tight regulation of this promoter is well suited for flavin replacement studies. Yeast are initially grown in the presence of riboflavin so that key metabolic flavin enzymes function with their normal coenzymes. After washing the cells and resuspension in fresh medium, MAO A or B is then expressed with the riboflavin analogue of interest in the culture medium. As shown in Fig. 2 , MAO is expressed only during galactose induction and exhibits catalytic activity only when exogenous riboflavin is present. The amount of MAO activity in galactoseinduced yeast strain RM2 is dependent on the concentration of exogenous riboflavin in the medium (Fig. 1) . Detectable MAO activity is observed only after the extracellular concentration of riboflavin exceeds 4 M. Thus, the small levels of riboflavin present in YPD growth media (Ͻ1.5 M) do not affect the amount of MAO activity observed.
Yeast auxotrophic for riboflavin equilibrate their intracellular riboflavin pool with the medium through transporter-mediated efflux and influx (45) . Therefore, washing the cells and resuspension in fresh medium containing the desired riboflavin analogue is expected to dilute any remaining intracellular riboflavin to undetectable levels. To confirm that intracellular FAD levels are also reduced, the amounts of protein-free cytosolic FAD in riboflavin auxotrophic yeast strain RM2 and the prototrophic parent strain W303.1B were determined by reconstitution of apoglucose oxidase from A. niger. Wild-type W303.1B cells contain 8.6 Ϯ 0.6 pmol of FAD/mg of cytosolic protein following galactose induction (Table II) . Under similar conditions, the riboflavin auxotrophic daughter strain RM2 (supplemented with 50 mg/liter riboflavin) contained 7.5 Ϯ 0.9 (87%) of the free cytosolic FAD present in the wild-type W303.1B strain. When strain RM2 was induced in the absence of exogenous riboflavin, the level of free FAD was below the detection limit of the apoglucose oxidase reconstitution assay (Ͻ0.3 pmol/mg protein or Ͻ5% of the FAD observed in RM2 cells induced in the presence of riboflavin). The amount of FAD detected in each culture correlated with the amount of mitochondrial MAO activity detected (Table II ). In the absence of added riboflavin, the level of FAD is insufficient to produce detectable amounts of active MAO.
Induction of MAO A or B in strain RM2 in the absence of exogenous riboflavin results in the synthesis and insertion of MAO apoenzyme into outer mitochondrial membranes (data shown and discussed below). Incubation of yeast mitochondria containing apo-MAO A or B with 500 M FAD does not produce catalytically active enzyme. These results are consistent with those reported by Abell and co-workers (9) using apo-MAO B expressed in riboflavin-depleted COS-7 cells.
Expression of MAO A and MAO B Containing Flavin Analogues-Since riboflavin-deficient S. cerevisiae express active
MAO A and MAO B, attempts were made to replace the native FAD cofactor with flavin analogues. RM2 yeast were grown on glucose in the presence of riboflavin and then divided into two identical portions, centrifuged, washed with water, and resuspended in galactose-containing media. One of the two cultures contained riboflavin and the other contained either no flavin or a riboflavin analogue. After 16 h of induction, mitochondria were prepared from both cultures, and the specific activities of MAO A or MAO B were determined.
MAO A was induced in the presence of 19 different flavin analogues (Table III) . Increasing the oxygen concentration from air saturation to ϳ1 mM oxygen does not alter MAO A reaction rates tested, suggesting that alteration of the flavin does not dramatically increase the K m O 2 of MAO A. MAO A-specific activity observed with each flavin analogue is compared with that observed in an identical riboflavin control culture. The results in Table III compare the MAO A-specific activity from each flavin analogue preparation as a percentage of the specific activity of the corresponding control culture. Similar experiments were conducted using RM2 yeast that expressed MAO B (Table III) . All MAO B assays contained saturating concentrations (ϳ1 mM) of oxygen to maximize the observed rate since the K m O 2 of MAO B is close to air saturation.
The catalytic data summarized in Table III are qualitative in that catalytic activities are measured only at substrate concentrations known to be saturating with the native forms of the enzymes. A detailed kinetic study of each MAO produced with a bound flavin analogue is beyond the scope of this study. The levels of flavinylation of MAO A/B with each analogue are qualitatively determined (see below) thus precluding the direct comparison of turnover numbers for the various analogues. Despite these uncertainties, the data in Table III show several clear trends. Flavin analogues containing a halogen moiety at position 7 of the isoalloxazine ring show consistently higher specific activities than riboflavin controls. This may reflect a contribution from an increase in oxidation-reduction potential of this class of analogue relative to riboflavin (46). Analogues Mitochondria were isolated after 16 h of growth, and 10 g of protein were separated by SDS-PAGE and electroblotted to nitrocellulose. MAO A was detected using a rabbit polyclonal antibody raised against purified recombinant MAO A (anti-MAO antibody). 2 As will be demonstrated below, 8-halogen-substituted flavins are incorporated into MAO as an 8-thioflavin. Analogues containing a 7␣-methyl group show reduced catalytic activities relative to riboflavin controls. This may reflect a steric alteration of the bound flavin in the binding sites since 7␣-methylflavins do not exhibit a major difference in oxidation reduction potential from that of riboflavin. The presence of the 7-methyl group on the benzenoid ring of the flavin is not required, as 7,8-nor-8-chlororiboflavin produces active MAO A. Modification of the flavin ribityl side chain by removal of the 2Ј-hydroxyl group also does not significantly alter the activity of MAO A in contrast to the observed decrease in activity observed in several other flavoenzymes (33, 47) .
Several analogues showed no activity with either MAO A or MAO B. 5-Deaza-5-carbariboflavin does not produce active enzyme although it is imported and converted to FAD by yeast auxotrophic for riboflavin (17) . As previously discussed, the analogues 8-nor-8-amino-riboflavin and N(3)-methyl-riboflavin are not converted to FMN by the yeast flavokinase and do not support MAO activity. 7,8-Nor-7-chloro-riboflavin produced no detectable MAO A and/or B activity which suggests its FAD form is not bound to the apoenzyme in a manner that would support catalytic activity.
Covalent Attachment of Flavin Analogues to MAO A and B
Expressed in Yeast Strain RM2-The covalent attachment of each flavin analogue to MAO A and B was analyzed with a polyclonal antiserum that recognizes protein-attached FAD molecules (20) . Outer mitochondrial membrane proteins were selectively solubilized from each flavin analogue sample using digitonin. Equal amounts of protein were separated by SDS-PAGE and analyzed by Western blotting. Each flavin analogue sample was probed with an antibody specific for recombinant human liver MAO or the anti-flavin antibody previously described. The MAO A and MAO B Western blots are shown in Figs. 3 and 4 , respectively. The anti-MAO blots in both Figs. 3 and 4 show that expression levels of MAO A and MAO B are essentially unchanged regardless of the presence or absence of riboflavin or flavin analogue. The anti-flavin antibody cross-reacts with either MAO A and B as well as small quantities of contaminating succinate dehydrogenase (SDH) from the mitochondrial matrix (7, 8) (upper band seen in Figs. 3B and 4B ). Flavin analogues that produce active enzyme are found to be covalently attached to MAO A and/or B (lower bands seen in Figs. 3B and 4B ). These data show that both enzymes exhibit similar specificities for covalent binding of flavin analogues.
MAO induced in the presence of 8-nor-8-halogen-riboflavin analogues contains a flavin cofactor covalently attached via a linkage that was unstable under reducing SDS-PAGE conditions. Based on this instability and the known electrophilicity of 8-nor-8-halogen-riboflavins (34), covalent attachment of this analogue class is proposed to involve an 8-nor-8-S-thioflavin linkage (direct spectral evidence for the formation of this linkage is shown in Fig. 6 ). Treatment of a model 8-nor-8-S-thioflavin compound, 8-nor-8-S-(N-acetylcysteinyl)-riboflavin, with SDS-PAGE sample buffer for 5 min at 90°C resulted in Ͼ95% degradation of the 8-nor-8-S-thioflavin compound (data not shown). This result suggests that with these MAO samples, the suspected 8-nor-8-S-thioflavin linkage was significantly degraded during sample preparation and/or electrophoresis. Purification of MAO A induced in the presence of 8-nor-8-chlororiboflavin was required to obtain enough sample to detect the covalently attached flavin analogue by Western blot analysis (Fig. 3C) . Interestingly, the putative 8-nor-8-S-thioflavin linkage between MAO A and the analogue 7,8-nor-8-chlororiboflavin appears to be more stable under SDS-PAGE conditions (Fig. 3B ) and required no additional purification. The reason for this enhanced stability is unknown.
The anti-flavin antibody was observed to be more immunoreactive with 8␣-N-histidyl-flavin linkages (e.g. SDH) than 8␣-S-thioether linkages (e.g. MAO) (20) . This differential response also extends to different flavin analogues. Antibody responses in Figs. 3B and 4B vary among the differing analogues tested, and the relative intensities do not correlate with enzyme activity (Table III) . Typical Western blots of MAO A contained 200 ng of MAO A protein per lane, and the lower limit of sensitivity of the anti-flavin antibody is approximately 10 -20 ng of FADcontaining MAO A (data not shown). Therefore, if only 5-10% of the total MAO A is flavinylated, this level should be detectable by the anti-flavin antibody assuming an immune response similar to that seen with FAD. Our experience with this antisera is that it exhibits a broad specificity for covalent flavins ranging from the FMN levels to MAO preparations in which the flavin is covalently modified by mechanism-based inhibitors such as clorgyline or pargyline, which form N(5)-flavocyanine adducts (48) .
The flavin analogues that did not produce active MAO showed no detectable response to the anti-flavin antibody (Figs. 3B and 4B ). These flavin analogues either are not covalently incorporated into MAO or, less likely, are not recog-2 S. Ghisla, personal communication. nized by the anti-flavin antibody. It should be noted that of those analogues not exhibiting covalent attachment or activity, neither N(3)-methylriboflavin nor 8-nor-8-aminoriboflavin are converted to FAD by the organism (see above) and therefore neither of these analogues are expected to be covalently bound or exhibit activity. 5-Carba-5-deazariboflavin converted to FAD by the organism (42), however, is not expected to exhibit catalytic activity due to its non-reactivity with O 2 . The finding of no covalent incorporation into these enzymes will be discussed in a later section.
Purification and Characterization of MAO A Containing 7-Nor-7-Bromoriboflavin from Yeast Strain RM3-Purification
of MAO A containing a flavin analogue was conducted to demonstrate that covalent attachment of analogues occurred at the appropriate residue of MAO and that the 7-nor-7-halogen analogues were not altered by the yeast cell. MAO A containing 7-nor-7-bromo-FAD was expressed and partially purified from rib5 yeast strain RM3. This strain expresses much higher levels of MAO A than strain RM2, although catabolic repression of the glyceraldehyde-3-phosphate dehydrogenase promoter is not as strong as with the GAL10/CYC1 promoter used in strain RM2 (Fig. 2) . The leaky transcription in strain RM3 precludes growth of cells on glucose and riboflavin followed by induction in galactose and flavin analogues. To ensure that all MAO molecules contain only the flavin analogue, the yeast must be grown and induced with the flavin analogue.
Growth of RM3 yeast using 7-nor-7-bromo-riboflavin as the sole source of flavin resulted in cell densities approximately one-half that seen with riboflavin. Expression of MAO A containing 7-nor-7-bromo-FAD in 22 liters of yeast resulted in 14 units of kynuramine oxidase activity in crude lysates. The enzyme was purified by the procedure of Weyler and co-workers (19, 35) with a 21% yield. The specific activity of this preparation was determined to be 0.2 units/mg (less than 20% that exhibited by MAO A purified from RH218 yeast). The electronic absorbance spectrum of this preparation exhibited a flavin-like spectrum in the visible spectral region.
A portion of the 7-nor-7-bromoriboflavin containing MAO A sample (0.16 units) was acid-precipitated and proteolyzed. The visible absorbance spectrum of the digested protein sample showed a flavin spectrum with an absorbance maximum at 450 nm (data not shown). Peptides produced by proteolysis were treated with phosphodiesterase and acid phosphatase to convert FAD-containing peptides to the riboflavin form. This mixture was separated by analytical and microbore HPLC. A single fluorescent fraction that displayed a UV absorbance spectrum consistent with a flavin-containing peptide was isolated and analyzed by MALDI-TOF mass spectrometry. The mass obtained for this peptide (926.3 atomic mass units) is within experimental error of the mass calculated for the expected tryptic/chymotryptic MAO A peptide Ser-Gly-Gly-(8-␣-S-7-nor-7-bromo-riboflavin-Cys)-Tyr (Fig. 5) . Edman degradation sequencing of the isolated peptide showed the sequence to be identical to the expected Ser-Gly-Gly-X-Tyr peptide. These data show that the expected site of covalent linkage of the flavin to the protein occurs in the recombinant enzyme and that thiol substitution occurs at the 8-methyl group rather than at the 7-bromo group. 
Purification and Characterization of MAO A Containing an
8-Nor-8-S-Thioflavin
Linkage from Yeast Strain RM3-The instability of the flavin-protein linkage in MAO induced with 8-nor-8-halogen-riboflavin analogues to heat and reducing agents suggested the presence of an 8-nor-8-S-thioflavin linkage. To characterize further the enzyme containing this analogue, MAO A was expressed and partially purified from 22 liters of RM3 yeast grown exclusively on 8-nor-8-chlororiboflavin. Enzyme activity was found to be unstable to solubilization and fractionation as only 0.02 units of kynuramine oxidase activity were observed after purification. The visible absorbance spectrum of the enzyme after denaturation in guanidine exhibits a narrow peak centered at 483 nm with a shoulder at 420 nm (Fig. 6 ). All preparations of MAO A isolated from RM3 yeast showed varying amounts of this 420 nm absorption which may be due to a hemoprotein contaminant. The denatured enzyme was dialyzed overnight against 400 volumes of 4 M guanidine to remove any non-covalently bound flavin. After dialysis, the visible absorbance spectrum of the enzyme solution was unchanged after correction for dilution (Fig. 6) , indicating that the cofactor was covalently attached to the enzyme. Reduction of the enzyme with dithionite resulted in a complete loss of the 483 nm absorbance and some reduction in the 420 nm shoulder (Fig. 6) . The absorbance spectrum of the oxidized enzyme (Fig. 6) is very similar to that of 8-nor-8-S-thioflavin (34, 49) . These data demonstrate that 8-nor-8-halogen-substituted flavins are covalently incorporated into MAO A as an 8-thio-FAD with the thiol group likely due to Cys-406. Due to the similar behavior exhibited with MAO B with this class of flavin analogues, the same type of linkage undoubtedly occurs.
Attempts were made to determine the peptide site for 8-thioflavin formation. MAO A was purified from yeast grown on 8-nor-8-chlororiboflavin analogue and proteolyzed and the peptides fractionated as described for MAO A containing 7-nor-7-bromo-FAD (see above). A single fluorescent peptide was isolated by subsequent purifications on analytical and microbore HPLC. This peptide displayed an ultraviolet absorbance spectrum and intense fluorescence more consistent with an 8-nor-8-S-thioriboflavin linkage in which the thioether linkage has been oxidized. These properties were consistent with oxidation of the 8-nor-8-S-thioflavin to an 8-nor-8-S-sulfoxo or 8-nor-8-Ssulfonylriboflavin (49) during or following proteolysis. by Edman degradation or to characterize their mass by MALDI-TOF mass spectrometry were unsuccessful.
DISCUSSION
Flavin analogues provide a useful tool to probe both the structure and mechanism of enzymes containing a flavin cofactor. The approach outlined in this paper extends this application to those flavoenzymes containing a covalently bound flavin that can be heterologously expressed in S. cerevisiae. Alternatively, this approach may be useful for flavin analogue incorporation into those flavoenzymes containing non-covalent flavins but are refractory to reversible resolution of the bound flavin by known techniques. The major limitation of the approach is the ability of the flavokinase and FAD synthetase of yeast to convert the riboflavin analogue under investigation to the FMN and FAD levels. Of the analogues tested in this study, N(3)-methylriboflavin and 8-nor-8-aminoriboflavin are inactive with the yeast flavokinase system. The failure to observe incorporation of either of these analogues into MAO A or MAO B is undoubtedly due to a requirement for the FAD coenzyme form for covalent incorporation.
The use of mutant strain RM2 allows growth of the organism on normal riboflavin for optimal formation of other metabolically essential flavoenzymes and permits the use of flavin analogues that might exhibit anti-vitaminic activity for testing of incorporation into expressed MAO. The flavin concentration requirement for optimal MAO activity is relatively high compared with the trace levels of the vitamin found in the growth media or in metabolic pools of the organism. Although strain RM3 expresses high levels of MAO A, the "leakiness" of MAO expression requires that only the riboflavin analogue of interest be used both for growth of the organism as well as for MAO induction. This situation may place limits on flavin analogues used in that they would also have to be functional in other key metabolic flavoenzymes in order for the organism to grow.
From the data presented in Table III and in Figs. 3 and 4 , a large number of 7-or 8-substituted flavin analogues are covalently incorporated into MAO A and into MAO B and support catalytic activity. The two enzymes appear to exhibit similar specificities as to which flavin analogues are incorporated and support catalytic activity. One major difference between the two enzymes is the higher catalytic activity exhibited by MAO B with 7␣-methyl, 8␣-methylriboflavin than is observed with MAO A. The results obtained using 7␣-methylriboflavin and 8␣-methylriboflavin in the system described here differ somewhat from those obtained by Lambooy and co-workers (13-15) using riboflavin-depleted rats. Both 7␣-methylriboflavin and 8␣-methylriboflavin significantly reduced the observed MAO activity (both MAO A and MAO B) in riboflavin-depleted rats. In the yeast expression system (relative to riboflavin), 7␣-methylriboflavin decreases both MAO A and MAO B activities, whereas 8␣-methylriboflavin decreases MAO A activity and results in an enhanced MAO B activity. Understanding the detailed molecular basis for this difference is beyond the scope of this paper and will ultimately be resolved from x-ray structural elucidation of MAO A and MAO B. This behavior does support the notion of quite different structures about the active sites which is apparent from a comparative study of substrate substituent effects on binding and rates of flavin reduction that are ongoing in this laboratory. The lowered activities of 7␣-methyl-substituted flavins with MAO A suggest steric effects about the benzenoid ring of the bound flavin that influence the expression of catalytic activity in a currently undefined manner. The effect of removing the 2Ј-hydroxy group from the flavin ribityl side chain decreases the turnover numbers of lipoamide dehydrogenase, mercuric ion reductase, and glutathione reductase (50) and results in an inactive form of general acyl-CoA dehydrogenase (47) . 2Ј-Deoxyriboflavin is incorporated covalently into MAO A, and no significant difference (relative to riboflavin) in catalytic activity is observed (Table III ). These results demonstrate that the 2Ј-hydroxyl group on the flavin side chain is not required for either process in MAO A.
The data on purified MAO A demonstrates conclusively that the covalent incorporation of 8-halogen-8-nor-substituted flavins occurs by a nucleophilic attack of the thiol of Cys-406 on the 8-halogenated position of the flavin as shown in Scheme4. This reaction has been shown previously in Massey's laboratory to occur in solution on reaction of 8-nor-8-chloroflavin with N-acetylcysteine. We have employed this reaction to prepare a model flavin peptide that exhibits the same HPLC retention time and fluorescence properties as that of the peptide derived from the enzyme. These data support Cys-406 as the attacking thiol group and suggest the 8-nor-8-halogenated FAD binds to a partially folded form of MAO A containing a FAD-binding site prior to nucleophilic displacement. Further evidence for the correct thiol (Cys-406) as the nucleophile is the demonstration that 7-nor-7-bromo-FAD forms a covalent 8␣-S-thioether linkage to Cys-406 resulting in a peptide with the expected sequence. Our failure to characterize the 8-thioflavin peptide by normal Edman sequencing and MALDI mass spectrometric techniques is probably due to the enhanced reactivity of this flavin linkage and its lability to oxidative alterations during normal peptide purification techniques.
Two flavin analogues were specifically synthesized to determine if attachment of the flavin cofactor to MAO could occur by a halogen moiety alone at either Cys-7 or Cys-8 of the flavin ring. The analogues 7,8-nor-7-chlororiboflavin and 7,8-nor-8-chloro-riboflavin were examined for activity and covalent attachment to MAO A. Only 7,8-nor-8-chlororiboflavin produced active flavinylated MAO A indicating that, in agreement with the results described here on 7-nor-7-bromoriboflavin, no nucleophilic attack of the Cys-406 thiol on the 7-halogen substituent occurs. This result also suggests that no substituent is required at Cys-7 for covalent flavinylation or enzyme activity.
The demonstration of a direct nucleophilic attack of the cysteinyl thiol on the 8-halogen substituent of the flavin provides supporting evidence for the quinone methide mechanism for covalent incorporation of flavins into proteins as originally suggested by Frost and Rastetter (1) (Scheme 5). Consistent with this mechanism is the absence of a covalent attachment between the 7,8-nor-7-chloroflavin analogue and MAO A. This analogue does not contain a potential electrophilic site for nucleophilic attack by the cysteine thiolate. Failure of 5-carba-SCHEME 4. Mechanism of 8-thioflavin formation in MAO. SCHEME 5. Proposed quinone-methide mechanism for covalent flavin incorporation into MAO.
5-deazariboflavin to form a covalent linkage with MAO A or B is likely due to the inability of the enzyme-flavin adduct to be reoxidized to form a stable 8␣-S-thioether linkage (Scheme 4). No evidence is apparent for any requisite flavin ring modification prior to covalent incorporation as has been suggested previously (9) . If the mechanism shown in Scheme 4 is operative, then one predicts that covalent attachment of 8␣-methylriboflavin analogues to MAO is expected to occur at the 8␣-carbon and not the 8␤-carbon. Work is underway in this laboratory to test this prediction.
The observation that all analogues producing active enzymes are covalently attached to MAO A or B suggests that covalent flavinylation of either enzyme is required for activity. This conclusion is inconsistent with the report by Hiro and colleagues (51) who have described a C406A mutant of rat liver MAO A that exhibits catalytic activity without benefit of covalent flavin attachment. We have confirmed this finding with the same mutant form of human MAO A expressed in S. cerevisiae. 3 These observations demonstrate that covalent flavin incorporation is not an absolute requirement for catalytic activity in MAO A. Similar results have been demonstrated with mutants of Escherichia coli fumarate reductase (52) which contain FAD rather than 8␣-N(3)-histidyl-FAD. Thus, the basis for covalent attachment of flavins in certain enzymes may have no mechanistic significance other than to prevent dissociation of the flavin coenzyme from its binding site.
